VANOLI, JENNIFER
 Distribuzione geografica
Continente #
EU - Europa 650
NA - Nord America 530
AS - Asia 159
SA - Sud America 4
AF - Africa 1
OC - Oceania 1
Totale 1.345
Nazione #
US - Stati Uniti d'America 524
DE - Germania 177
IT - Italia 170
IE - Irlanda 169
HK - Hong Kong 73
SE - Svezia 64
CN - Cina 47
SG - Singapore 20
GB - Regno Unito 16
IN - India 15
AT - Austria 10
FI - Finlandia 9
FR - Francia 7
CA - Canada 6
NL - Olanda 6
RU - Federazione Russa 6
UA - Ucraina 6
BR - Brasile 4
DK - Danimarca 4
LB - Libano 2
PT - Portogallo 2
BE - Belgio 1
JP - Giappone 1
KR - Corea 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
PL - Polonia 1
RO - Romania 1
SC - Seychelles 1
Totale 1.345
Città #
Dublin 163
Frankfurt am Main 163
Ann Arbor 116
Chandler 87
Hong Kong 73
New York 49
Milan 46
Fairfield 37
Ashburn 35
Shanghai 21
Princeton 19
Monza 18
Wilmington 15
Beijing 14
Seattle 13
Dearborn 11
Houston 9
Lawrence 9
Pune 9
Vienna 9
Cambridge 7
Lissone 7
London 7
Altamura 6
Boardman 6
Bergamo 5
Helsinki 5
Los Angeles 5
Bonndorf 4
Cagliari 4
Groningen 4
Lappeenranta 4
São Paulo 4
Toronto 4
Woodbridge 4
Jacksonville 3
Middle River 3
Nanjing 3
Padova 3
San Diego 3
Assago 2
Bologna 2
Brembate 2
Brembate di Sopra 2
Chicago 2
Dalmine 2
Desio 2
Hounslow 2
Huizen 2
Kunming 2
Lisbon 2
Missaglia 2
Modena 2
Morsano 2
Mumbai 2
Nanchang 2
New Bedfont 2
Novara 2
Ome 2
Paese 2
Paris 2
Rome 2
Senago 2
Shenyang 2
Trento 2
Andover 1
Atlanta 1
Auckland 1
Bari 1
Brunflo 1
Brussels 1
Buffalo 1
Carate Brianza 1
Cedar Knolls 1
Ciampino 1
Dallas 1
Edinburgh 1
Edmonton 1
Falkenstein 1
Falls Church 1
Fremont 1
Gdansk 1
Graz 1
Guanzate 1
Gunzenhausen 1
Hongtong 1
Hunedoara 1
Islington 1
Jinan 1
Kiev 1
Mahé 1
Naples 1
New Delhi 1
Nottingham 1
Osaka 1
Parma 1
Philadelphia 1
Redmond 1
Richland 1
San Francisco 1
Totale 1.092
Nome #
Vitamin B12 deficiency-induced pseudothrombotic microangiopathy without macrocytosis presenting with acute renal failure: a case report 174
Granulomatosis with polyangiitis presenting with diffuse alveolar hemorrhage requiring extracorporeal membrane oxygenation with rapid multiorgan relapse: A case report 167
DIFFERING EFFECTS OF RENAL DENERVATION ON BLOOD PRESSURE AND SYMPATHETIC NERVE TRAFFIC: A SYSTEMATIC REVIEW AND META-ANALYSIS 92
Sympathetic Neural Mechanisms Underlying Attended and Unattended Blood Pressure Measurement 87
L’IMPATTO DELL’AUMENTO DELLA MASSA VENTRICOLARE SINISTRA SULLA MORTALITA’ CARDIOVASCOLARE: UNO STUDIO PROSPETTICO OSSERVAZIONALE. 75
Metronidazole-induced hepatotoxicity in a patient with xeroderma pigmentosum: A case report 64
White-Coat Hypertension Without Organ Damage: Impact on Long-Term Mortality, New Hypertension, and New Organ Damage 63
Uric Acid, Hypertensive Phenotypes, and Organ Damage: Data from the Pamela Study 61
INCIDENT AORTIC ROOT DILATATION IN THE GENERAL POPULATION: FINDINGS FROM THE PAMELA STUDY 56
Transient effects of carotid baroreflex stimulation via the neck chamber device on central venous pressure 54
Elevated resting heart rate as independent in-hospital prognostic marker in COVID-19 51
Autonomic cardiovascular alterations as therapeutic targets in chronic kidney disease 47
WHITE-COAT HYPERTENSION WITHOUT ORGAN DAMAGE: IMPACT OF LONG-TERM MORTALITY, NEW HYPERTENSION AND NEW ORGAN DAMAGE 45
Uric acid relationships with lipid profile and adiposity indices: Impact of different hyperuricemic thresholds 44
ELEVATED RESTING HEART RATE AS INDEPENDENT IN-HOSPITAL PROGNOSTIC MARKER IN COVID-19 41
Association between Berlin questionnaire index and blood pressure, organ damage and metabolic profilein a general population 39
Reproducibility of blood pressure phenotypes identified by office and ambulatory blood pressure in treated hypertensive patients. Data from the PHYLLIS study 33
Comparison of electrocardiographic versus echocardiographic detection of left ventricular mass changes over time and evaluation of new onset left ventricular hypertrophy 26
Heart rate thresholds for cardiovascular risk and sympathetic activation in the metabolic syndrome 26
Coffee consumption, clinic, 24-hour and home blood pressure. Findings from the PAMELA study 24
Impact of the Increase in Left Ventricular Mass on the Risk of Long-Term Cardiovascular Mortality: A Prospective Cohort Study 24
Relationships between sympathetic markers and heart rate thresholds for cardiovascular risk in chronic heart failure 23
Uric acid relationship with lipids and adiposity indices: role of different hyperuricemia cut-off 23
Correction: Relationships between sympathetic markers and heart rate thresholds for cardiovascular risk in chronic heart failure 23
Sympathetic Neural Mechanisms in Hypertension: Recent Insights 21
WHITE-COAT HYPERTENSION WITHOUT ORGAN DAMAGE: IMPACT OF LONG-TERM MORTALITY, NEW HYPERTENSION AND NEW ORGAN DAMAGE 15
INCIDENT AORTIC ROOT DILATATION IN THE GENERAL POPULATION: FINDINGS FROM THE PAMELA STUDY 13
Renal Denervation in End-Stage Renal Disease: Current Evidence and Perspectives 8
DIFFERENTIAL EFFECTS OF RENAL DENERVATION ON SKIN AND MUSCLE SYMPATHETIC NERVE TRAFFIC IN RESISTANT AND UNCONTROLLED HYPERTENSION 5
DIFFERING EFFECTS OF RENAL DENERVATION ON BLOOD PRESSURE AND SYMPATHETIC NERVE TRAFFIC: A SYSTEMATIC REVIEW AND META-ANALYSIS 5
EFFECTS OF CAROTID BARORECEPTOR STIMULATION ON REGIONAL SYMPATHETIC ACTIVITY IN CHRONIC HEART FAILURE 4
DIFFERING EFFECTS OF RENAL DENERVATION ON BLOOD PRESSURE AND SYMPATHETIC NERVE TRAFFIC: A SYSTEMATIC REVIEW AND META-ANALYSIS 3
ELEVATED RESTING HEART RATE AS INDEPENDENT IN-HOSPITAL PROGNOSTIC MARKER IN COVID-19 3
Totale 1.439
Categoria #
all - tutte 7.018
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.018


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201918 0 0 0 0 0 0 0 0 0 5 5 8
2019/202053 8 5 5 4 3 9 7 2 6 3 0 1
2020/202172 0 1 2 4 1 2 9 8 15 12 8 10
2021/2022187 13 14 27 8 4 3 13 22 4 19 22 38
2022/2023495 28 95 56 55 53 82 32 27 17 14 20 16
2023/2024579 28 24 38 45 73 170 90 38 55 18 0 0
Totale 1.439